Publication: Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study
Date
Date
Date
Citations
Amstutz, A., Chammartin, F., Audigé, A., Eichenberger, A. L., Braun, D. L., Amico, P., Stoeckle, M. P., Hasse, B., Papadimitriou-Olivgeris, M., Manuel, O., Bongard, C., Schuurmans, M. M., Hage, R., Damm, D., Tamm, M., Mueller, N. J., Rauch, A., Günthard, H. F., Koller, M. T., … et al. (2024). Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study. Journal of Infectious Diseases, 230(4), e847–e859. https://doi.org/10.1093/infdis/jiae291
Abstract
Abstract
Abstract
Background Bivalent messenger RNA (mRNA) vaccines, designed to combat emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, incorporate ancestral strains and a new variant. Our study assessed the immune response in previously vaccinated individuals of the Swiss HIV Cohort Study (SHCS) and the Swiss Transplant Cohort Study (STCS) following bivalent mRNA vaccination.
Methods Eligible SHCS and STCS participants received approved bivalent mRNA SARS-CoV-2 vaccine
Metrics
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page Range
Page Range
Page Range
Page end
Page end
Page end
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Funder name
Funder name
Funder name
Roche
SNSF
Janggen Pöhn Foundation
SNSF
SNSF
SNSF
University of Basel
Grant ID
Grant ID
Grant ID
221860
196245
177522
201369
Project Title
Project Title
Project Title
Immediate and pre-emptive therapies for SARS CoV-2 positive and negative patients with high risk for Covid-19 pneumonia: Immunocompromised Collaborative Host Swiss Cohorts Based Trial Platform Initiative
Swiss Transplant Cohort Study
Swiss HIV Cohort Study
Junior Research Fund
Metrics
Citations
Amstutz, A., Chammartin, F., Audigé, A., Eichenberger, A. L., Braun, D. L., Amico, P., Stoeckle, M. P., Hasse, B., Papadimitriou-Olivgeris, M., Manuel, O., Bongard, C., Schuurmans, M. M., Hage, R., Damm, D., Tamm, M., Mueller, N. J., Rauch, A., Günthard, H. F., Koller, M. T., … et al. (2024). Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study. Journal of Infectious Diseases, 230(4), e847–e859. https://doi.org/10.1093/infdis/jiae291
